A public genome project will enhance healthcare quality and reduce costs
The ability to predict diseases such as type 2 diabetes would repay the investment many times over
Irish genetic discoveries have major international impact, and a public genome project would attract international genomics and pharmaceutical companies to Ireland
Ireland needs to join the growing number of countries performing national public genome projects. Our European neighbours in Finland, Denmark, Estonia and England have already embarked on such projects, as have countries like the United States and Japan, with Dubai the most recent to announce that it is joining this pioneering group.
The investments being made are substantial. Finland, whose population is closest in size to Ireland, is investing €59 million. The English 100,000 Genomes Project invested £300 million initially, Estonia has already spent €12 million, while Germany has allocated €360 million for a personalised medicine initiative involving the generation of genomic information from its citizens.